Atlas Trials

Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

Clinical trial NCT00942058 · TERMINATED

Trial details

NCT number
NCT00942058
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Status
TERMINATED
Study type
OBSERVATIONAL
Metastatic Kidney CancerMetastatic Renal Cell Carcinoma
Start date
2009-06-01
Primary completion
2013-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.